このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Use of Various Types of Introducers in Conventional Radial Access (TIRE)

2026年5月8日 更新者:Aleksandr V. Bocharov, PhD, MD、Pirogov Russian National Research Medical University

The purpose of this intervention study is to compare different types of radial introducers used in traditional radial access in terms of the incidence of complications.

The main questions it aims to answer are:

  1. Does a smaller outer diameter of the introducer reduce the risk of complications associated with radial access?
  2. Does the presence of an outer hydrophilic coating on the introducer reduce the risk of complications associated with radial access?
  3. Does the use of an introducer with a smaller outer diameter and an outer hydrophilic coating reduce the risk of complications associated with radial access? The researchers will compare the number of complications associated with radial access when using conventional diameter, uncoated radial introducers, conventional diameter introducers with an outer hydrophilic coating, or reduced outer diameter introducers with an outer hydrophilic coating.

During the scheduled revascularization procedure, the participants will undergo radial artery catheterization using one of the types of introducers. Complications from the radiation access will be recorded by doctors within 72 hours after the intervention.

調査の概要

詳細な説明

Objective: to compare different types of radial introducers used in conventional radial access by the frequency of complications.

Scientific hypotheses:

  1. The risk of acute radial artery occlusion depends on the outer diameter of the introducer.
  2. The risk of acute radial artery occlusion depends on the presence of an outer hydrophilic coating on the introducer.
  3. The risk of persistent radial artery spasm depends on the presence of an outer hydrophilic coating on the introducer.
  4. The risk of persistent radial artery spasm depends on the outer diameter of the introducer.

Patients were enrolled by endovascular specialists with experience of at least 250 radial-access procedures per year.

Inclusion criteria: clear pulsation of the right radial artery, indications for percutaneous coronary intervention.

Exclusion criteria: previous unsuccessful radial artery catheterization; concomitant pathology limiting patient survival; disorders of the blood coagulation system (hemophilia, thrombocytopathy, etc.); previous coronary artery bypass grafting; occlusion of the right radial artery.

The required sample size was calculated using the method of M. Bland for a high-precision study. The required significance level (α) was 0.001 and the statistical power was 95%. The expected rate of radial artery occlusion in the Rad, Rad polymer, and Rad slender groups was assumed to be 12%, 8%, and 8%, respectively. Under these conditions, the calculated sample size was 2723 patients. The planned loss during the study was 20%. Thus, the minimum sample size was 3268 patients.

The study had an experimental design and complied with the CONSORT protocol. A simple randomization method using a random-number generator was chosen. The type of randomization was permuted block randomization. The total block size was 3000, and the allocation ratio between the groups was 1:1:0.7.

Puncture of the right radial artery was performed after local anesthesia with a 2% lidocaine solution. The radial artery was punctured at the typical site using the puncture needle included in the introducer set, with only the anterior wall being punctured. The type of introducer was selected by randomization using a random-number method, and depending on this assignment the patient was allocated to one of the groups.

All patients underwent percutaneous coronary angioplasty with coronary artery stenting via the right radial artery. The radial artery catheterization technique did not differ between groups. The type of introducer was selected by randomization using a random-number method, and depending on this assignment the patient was allocated to one of the groups. In the Rad group , introducers without a hydrophilic coating were used; in the Rad polymer group , introducers with a hydrophilic coating were used; and in the Rad slender group , thin-walled introducers with a hydrophilic coating were used. The access site was examined within 3 hours after the intervention and then, in the absence of complaints, again at bandage removal. After bandage removal, patients underwent ultrasound examination to confirm radial artery patency. Complications from the radiation access will be recorded by doctors within 72 hours after the intervention.

研究の種類

介入

入学 (実際)

3307

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Kostroma Oblast
      • Kostroma、Kostroma Oblast、ロシア、156013
        • E.I. Korolev Kostroma Regional Clinical Hospital
    • Moscow
      • Moscow、Moscow、ロシア、119071
        • Central Clinical Hospital of St. Alexy Metropolitan of Moscow of the Moscow Patriarchate of the Russian Orthodox Church

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • clear pulsation of the right radial artery
  • indications for percutaneous coronary intervention

Exclusion Criteria:

  • previous unsuccessful radial artery catheterization
  • concomitant pathology limiting patient survival
  • disorders of the blood coagulation system (hemophilia, thrombocytopathy, etc.)
  • previous coronary artery bypass grafting
  • occlusion of the right radial artery

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Rad classic
Introducer with a standard outer diameter and no external hydrophilic coating

The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

An introducer with a standard outer diameter and no external hydrophilic coating was inserted.

5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage.

The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery.

Complications were recorded within 3 days after the intervention.

実験的:Rad polymer
Introducer with a standard outer diameter and an outer hydrophilic coating

Description: The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

An introducer with a standard outer diameter and an outer hydrophilic coating was using.

5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage. The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery. Complications were recorded within 3 days after the intervention.

実験的:Rad slender
Introducer with a reduced outer diameter and an outer hydrophilic coating

Description: The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

An introducer with a reduced outer diameter and an outer hydrophilic coating was using.

5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage. The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery. Complications were recorded within 3 days after the intervention.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Acute radial artery occlusion after catheterization
時間枠:Within 72 hours after radial artery catheterization
Acute radial artery occlusion was confirmed by ultrasound examination
Within 72 hours after radial artery catheterization
Radial artery perforation
時間枠:Perioperative/Periprocedural
Angiography-confirmed perforation of the radial artery
Perioperative/Periprocedural
Radial artery false aneurysm
時間枠:Within 72 hours after radial artery catheterization
A false aneurysm of the radial artery was confirmed by ultrasound examination
Within 72 hours after radial artery catheterization
Hematoma by classification EASY Grade II
時間枠:Within 72 hours after radial artery catheterization
Hematoma by classification EASY Grade II was confirmed by ultrasound examination
Within 72 hours after radial artery catheterization
Persistent radial artery spasm
時間枠:Perioperative/Periprocedural
Persistent radial artery spasm confirmed by angiography
Perioperative/Periprocedural

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2019年1月28日

一次修了 (実際)

2025年12月16日

研究の完了 (実際)

2025年12月19日

試験登録日

最初に提出

2026年4月22日

QC基準を満たした最初の提出物

2026年5月6日

最初の投稿 (実際)

2026年5月7日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月13日

QC基準を満たした最後の更新が送信されました

2026年5月8日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

all personal data underlying the publication results

IPD 共有時間枠

Beginning 6 months and ending 1 years after the publication of results

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • CSR

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する